Sowell Financial Services’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,918
Closed -$81K 1938
2021
Q1
$81K Hold
1,918
﹤0.01% 1467
2020
Q4
$103K Buy
1,918
+624
+48% +$28.2K ﹤0.01% 1142
2020
Q3
$48K Buy
1,294
+33
+3% +$1.23K ﹤0.01% 1222
2020
Q2
$39K Hold
1,261
﹤0.01% 1248
2020
Q1
$35K Sell
1,261
-481
-28% -$14.4K ﹤0.01% 1173
2019
Q4
$51K Buy
1,742
+693
+66% +$16.5K ﹤0.01% 1146
2019
Q3
$20K Buy
+1,049
New +$24.6K ﹤0.01% 1281
2017
Q1
Sell
-1,000
Closed -$8K 463
2016
Q4
$8K Buy
+1,000
New +$8.57K ﹤0.01% 501

Other funds holding NEO

Sowell Financial Services's NEO Position: Q2 2021 in Review

Sowell Financial Services sold out of NeoGenomics (NEO) in Q2 2021, closing a stake of 1,918 shares — an estimated $81K sold.

Sowell Financial Services first reported a position in NEO in Q4 2016 and held it in 8 quarters. The position peaked at $103K in Q4 2020. 311 funds tracked by Wall St. Rank hold NEO as of Q2 2021.

  • Sowell Financial Services reported no remaining NeoGenomics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,918 NeoGenomics shares in Q2 2021, an estimated $81K.
  • Sowell Financial Services first reported a position in NeoGenomics in Q4 2016 and held it in 8 quarters.
  • Sowell Financial Services's NeoGenomics position peaked at $103K in Q4 2020.
  • 311 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.